Precigen Inc PGEN.OQ PGEN.O is expected to show a fall in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2025
The Germantown Maryland-based company is expected to report a 7.0% decrease in revenue to $666.67 thousand from $717 thousand a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for Precigen Inc is for a loss of 8 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Precigen Inc is $6.00, about 68.7% above its last closing price of $1.88
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.08
-0.08
-0.07
Beat
12.5
Dec. 31 2025
-0.04
-0.06
-0.06
Met
-6
Sep. 30 2024
-0.08
-0.08
-0.09
Missed
-12.5
Jun. 30 2024
-0.10
-0.10
-0.10
Met
-3.7
Mar. 31 2024
-0.09
-0.09
-0.10
Missed
-14.2
Dec. 31 2023
-0.08
-0.13
Missed
-67.7
Sep. 30 2023
-0.08
-0.08
-0.08
Met
-2.6
Jun. 30 2023
-0.10
-0.10
-0.08
Beat
20
This summary was machine generated August 8 at 13:17 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)